Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06593834
What this trial is testing

A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-host Disease
Yamin Fan 286
Testing effectiveness (Phase 2)Ended earlyNCT04623216
What this trial is testing

Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 24
Testing effectiveness (Phase 2)UnknownNCT00742300
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Charite University, Berlin, Germany
Testing effectiveness (Phase 2)Looking for participantsNCT02048332
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs)

Who this might be right for
Allogeneic Stem Cell TransplantViral InfectionViral Reactivation
Children's Hospital Medical Center, Cincinnati 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276698
What this trial is testing

Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell Lymphoma

Who this might be right for
NK T-Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 39
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Looking for participantsNCT02007356
What this trial is testing

Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Who this might be right for
Adenovirus InfectionEBVCytomegalovirus Infections+2 more
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)UnknownNCT03611231
What this trial is testing

Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

Who this might be right for
Experimental Tumor
Peking University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Not applicableUnknownNCT01596192
What this trial is testing

PETCT for Diagnosing and Monitoring Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
Rabin Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03346135
What this trial is testing

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaSecondary Amyloidosis
City of Hope Medical Center 31
Not applicableEnded earlyNCT02240381
What this trial is testing

Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

Who this might be right for
Diabetes MellitusMalignant Neoplasm
Vanderbilt-Ingram Cancer Center 22
Not applicableStudy completedNCT03188419
What this trial is testing

Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

Who this might be right for
Primary T-cell Immunodeficiency DisordersCommon Variable Immunodeficiency
National Cancer Institute (NCI) 161
Early research (Phase 1)WithdrawnNCT07498465
What this trial is testing

Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChildhood Acute Lymphoblastic Leukemia+3 more
Children's Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT07364617
What this trial is testing

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Who this might be right for
Graft vs Host Disease
Chang Gung Memorial Hospital 35
Early research (Phase 1)Looking for participantsNCT05443425
What this trial is testing

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT02389517
What this trial is testing

Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant

Who this might be right for
Plasma Cell MyelomaResidual Disease
University of Chicago 42
Not applicableEnded earlyNCT00578461
What this trial is testing

T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE

Who this might be right for
LeukemiaCancerLymphoma+2 more
Baylor College of Medicine 26
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Next Page